Home ResVita Bio

ResVita Bio

In operation
-
Developer of Skin Microbiome Platform
Basic
Enterprise Profile

Basic Information

ResVita Bio aims to restore and maintain skin vitality through engineered skin probiotics. By leveraging synthetic biology and metabolic engineering, we are developing a safe and versatile skin microbiome platform to continuously deliver therapies targeting the root causes of chronic skin conditions. ResVita Bio is developing a robust pipeline of products to treat inflammatory skin diseases such as Netherton Syndrome, atopic dermatitis, psoriasis, acne, and rosacea.
RESVITA BIO, INC.
California,United States of America
unclear
--
jobs@resvitabio.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Biotechnology
Concept
Dermatology Department Skin Diseases
Application Scenarios
Innovative Drugs